MedPath

Dilator Muscle Activity in Health and Sleep Apnea

Conditions
Obstructive Sleep Apnea
Interventions
Other: patients with OSA
Registration Number
NCT04254341
Lead Sponsor
Bnai Zion Medical Center
Brief Summary

The role of control of peri-pharyngeal muscle tone in the pathogenesis of obstructive sleep apnea (OSA) is obvious: pharyngeal obstruction occurs only during sleep; and pharyngeal collapse occurs in almost all healthy subjects during anesthesia. Better understanding of these control mechanisms may help identifying the central components of the pathogenesis of OSA.

Detailed Description

Study plan: Subjects will be studied first during wakefulness, while breathing against external resistors, to evaluate how are the peri-pharyngeal muscles recruited and activated to prevent pharyngeal collapse in the presence of negative intra-pharyngeal pressures. Thereafter, the same parameters will be evaluated during sleep, to assess muscle recruitment during intra-pharyngeal obstruction. The investigaors will record the electromyogram (EMG) of several dilator muscles, as well as the pressures above and below the area of pharyngeal collapse, and airflow.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  1. subjects that underwent regular sleep studies and found to have either moderate/severe OSA, or no OSA.
Exclusion Criteria
  1. hemophilia
  2. use of anti-coagulants -

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
patients with OSApatients with OSASubjects that underwent regular sleep studies (PSG) and found to have moderate/severe obstructive sleep apnea
subjects without OSApatients with OSASubjects that underwent regular PSG and found not to have sleep apnea
Primary Outcome Measures
NameTimeMethod
EMG activity of peri-pharyngeal muscles during wakefulness and sleep4 hours

EMG of peripharyngeal muscles will be measured during wakefulness (on external resistors) and sleep (during flow limitation), patients with OSA. EMG data will be presented as %max (0-100%).

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath